Evaluation of Disulfide Bond Scrambling in mAb peptide Mapping
Integrated FRPF Workflows for Structural MS Data Processing
Middle‑Down MS for Disulfide Mapping in Multispecific Proteins
Industry Perspectives on Preparing Validation-Ready NGS Workflows
Alison Waterfield May 17, 2026
Digitalizing CMC Processes at Novartis
Next Era of Bioprocessing: Driving Innovation through Digital CMC and AI
Unlocking NGS and Regulatory Synergy in GCT for Maximum Impact
NGS for Product Characterization in CGT: Biosafety and Genome Integrity
From Science to Compliance: Effective Validation of Genedata Selector
Genedata for Developability Across Biopharma R&D
Discover What’s New in Genedata Screener 2026
Genedata Biopharma Platform: Compliance-Ready
Screen Smarter: Automating Oligonucleotide Hit Selection
Lessons Learned from a Full-Scale GMP Validation of NGS Workflows
Unified Platform for Assay Development and GMP‑Ready NGS Analytics In-House
NGS‑MAM Framework for Comprehensive Vector Characterization
Automated NGS Data Analysis in AAV Upstream Manufacturing
Japan: Cutting Days from the DMTA Cycle in Discovery Research
NGS Made Practical: Meeting European Pharmacopoeia Standards
March 30, 2026
Integration Genedata Bioprocess Äkta UNICORN
Genedata Flexible Deployment for Any Digital Ecosystem.
AI-ready Bioprocess Unified Data Foundation
Genedata Selector Product Development Roadmap
Genedata’s Unparalleled Partner Symposium, 2026 Edition
March 12, 2026
Merck Automates MS-Based Workflows to Accelerate ADC Discovery
Automating LC-Based N-Glycan Analysis for CMC
Automated Assay Analytics from Discovery to CMC
Deriving an RNA Quality Scoring Method Applicable to a broad Range of Instruments
Data in Motion. Accelerated CMC Decisions.
Genedata Vico
Digital Transformation in Biopharma Data Management
Raed Hmadi March 2, 2026
Japan: Driving Next-Generation Discovery with Organoids
In-and-Out Characterization and CQA Monitoring of AAVs
Automation in Biopharma: Cell Line & Process Development
Raed Hmadi February 26, 2026
Japan: Increasing Efficiency of Antibody Discovery and Engineering Workflows
Streamlining CGT Data for TCR Engineering
Raed Hmadi February 25, 2026
Boehringer Ingelheim Accelerates NGS-Driven Cell Line Characterization
The Real Benefits (and Remaining Barriers) to AI in Biopharma
Mark Brewer, PhD, Ada Yee, PhD February 19, 2026
From Screening to Sequencing: Digital Backbone for Antibody Discovery
Japan: Utilizing Genedata Biologics’ Versatility for Cloud Software Integrations
Therapeutic Antibody Profiling with Genedata Biologics — AI & ML Framework for Cancer Drug Discovery
